Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6532
    +0.0032 (+0.49%)
     
  • OIL

    82.95
    +0.14 (+0.17%)
     
  • GOLD

    2,342.10
    +3.70 (+0.16%)
     
  • Bitcoin AUD

    97,734.69
    -4,064.77 (-3.99%)
     
  • CMC Crypto 200

    1,356.32
    -26.26 (-1.90%)
     
  • AUD/EUR

    0.6092
    +0.0022 (+0.36%)
     
  • AUD/NZD

    1.0957
    +0.0016 (+0.14%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,090.46
    +50.08 (+0.62%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,955.53
    -133.17 (-0.74%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Why Atea Pharmaceuticals Stock Is Sinking Today

Why Atea Pharmaceuticals Stock Is Sinking Today

Shares of Atea Pharmaceuticals (NASDAQ: AVIR) fell by as much as 14.4% in premarket trading Wednesday morning. The biotech's shares are sliding today in response to Roche's (OTC: RHHBY) decision to terminate its involvement in the development of the oral COVID-19 therapy known as AT-527. Atea Pharmaceuticals will reportedly regain full commercial rights to the drug on Feb. 10, 2022.